04:04 PM EDT, 08/21/2025 (MT Newswires) -- Health care stocks were mixed late Thursday afternoon with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund (XLV) falling 0.2%.

The iShares Biotechnology ETF (IBB) increased 0.1%.

In corporate news, CVS Health ( CVS ) decided not to include Gilead Sciences' ( GILD ) new HIV prevention drug Yeztugo in its commercial or Affordable Care Act plans for now, Reuters reported. CVS shares rose 1.2% and Gilead shed 2.4%.

ModivCare ( MODV ) shares sank 69% after the company said late Wednesday it filed for Chapter 11 protection in a Texas court.

Novo Nordisk's ( NVO ) weight-loss drug Wegovy is seeing increased demand in the UK as rival Eli Lilly ( LLY ) plans a significant price hike for its competing treatment, Mounjaro, Bloomberg reported. Novo shares rose 2%, and Eli Lilly ( LLY ) was up 0.6%.

Protagenic Therapeutics ( PTIX ) shares surged 78% after it said Thursday it has completed the first patient dosing in the multiple-dose portion of its ongoing phase 1 trial of PT00114, an investigational therapy based on a brain hormone that regulates stress and emotional balance.